BR9205493A - Composicao farmaceutica e processo para fabricacao de composicao farmaceutica - Google Patents

Composicao farmaceutica e processo para fabricacao de composicao farmaceutica

Info

Publication number
BR9205493A
BR9205493A BR9205493A BR9205493A BR9205493A BR 9205493 A BR9205493 A BR 9205493A BR 9205493 A BR9205493 A BR 9205493A BR 9205493 A BR9205493 A BR 9205493A BR 9205493 A BR9205493 A BR 9205493A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
manufacture
pharmaceutical
composition
Prior art date
Application number
BR9205493A
Other languages
English (en)
Inventor
Johnson Douglas Giles
Titus Allan Edward
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of BR9205493A publication Critical patent/BR9205493A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR9205493A 1991-11-15 1992-11-12 Composicao farmaceutica e processo para fabricacao de composicao farmaceutica BR9205493A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/793,043 US5169864A (en) 1991-11-15 1991-11-15 Unbuffered premixed ranitidine formulation
PCT/US1992/009817 WO1993009775A1 (en) 1991-11-15 1992-11-12 Unbuffered premixed ranitidine formulation

Publications (1)

Publication Number Publication Date
BR9205493A true BR9205493A (pt) 1994-04-05

Family

ID=25158922

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9205493A BR9205493A (pt) 1991-11-15 1992-11-12 Composicao farmaceutica e processo para fabricacao de composicao farmaceutica

Country Status (8)

Country Link
US (2) US5169864A (pt)
EP (1) EP0571575B1 (pt)
JP (1) JPH06505028A (pt)
AU (1) AU654421B2 (pt)
BR (1) BR9205493A (pt)
CA (1) CA2100466A1 (pt)
DE (1) DE69232409T2 (pt)
WO (1) WO1993009775A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5650421A (en) * 1995-03-31 1997-07-22 Baxter International Inc. Premixed famotidine formulation
JP4374250B2 (ja) * 2001-12-27 2009-12-02 テルモ株式会社 ファモチジン注射液
WO2007022105A2 (en) 2005-08-12 2007-02-22 Rubicon Research Pvt. Ltd. Stable pharmaceutical compositions, processes for making the same, and methods of their use
US20090178599A1 (en) 2008-01-15 2009-07-16 Environmental Energy Services, Inc. Process for operating a coal-fired furnace with reduced slag formation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021481A (en) * 1969-06-27 1977-05-03 Nyegaard & Co. A/S Amido derivatives of 2,4,6-triiodobenzoic acids containing at least one N-hydroxyalkyl and at least two hydroxyl groups
US4024271A (en) * 1971-03-09 1977-05-17 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3950033A (en) * 1974-02-22 1976-04-13 Wilcox Raymond J Vehicle wheel
CH608189A5 (pt) * 1974-12-13 1978-12-29 Savac Ag
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
AR222337A1 (es) * 1978-07-04 1981-05-15 Nyegaard & Co As Procedimiento para preparar una solucion esteril inyectable fisiologicamente aceptable de un agente de contraste de rayos x
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
US4955871A (en) * 1987-04-29 1990-09-11 Path Single-use disposable syringe
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation

Also Published As

Publication number Publication date
EP0571575A4 (pt) 1994-03-30
US5169864A (en) 1992-12-08
DE69232409D1 (de) 2002-03-21
US5304571A (en) 1994-04-19
WO1993009775A1 (en) 1993-05-27
EP0571575A1 (en) 1993-12-01
DE69232409T2 (de) 2002-11-07
CA2100466A1 (en) 1993-05-16
AU654421B2 (en) 1994-11-03
EP0571575B1 (en) 2002-02-06
JPH06505028A (ja) 1994-06-09
AU3075192A (en) 1993-06-15

Similar Documents

Publication Publication Date Title
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
PT98944A (pt) Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR9203707A (pt) Compostos,composicao,emprego de compostos,processo para a fotopolimerizacao de compostos e emprego de uma composicao
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9604894A (pt) Derivado de acetamida processo para a preparação do mesmo e uma composição farmacêutica contendo o mesmo
BR9406566A (pt) Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
BR9300660A (pt) Composicao de organossilicio,processo para prosducao da mesma e artigo de fabricacao
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
BR9201017A (pt) Composicao de amaciamento de tecido e processo para sua preparacao
BR9206950A (pt) Composição farmacêutica e processo para sua preparação
BR9301180A (pt) Processo para a preparacao de isocianatos e emprego
BR8904658A (pt) Composicao e processo para o aclaramento otico de materiais
BR9303864A (pt) Prosecco e conjunto para producao de blocos reofundidos
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
BR9202446A (pt) Composicao de dentifricio,dentifricio e processo para a preparacao de um dentifricio
BR9301448A (pt) Composicao e processo para sua preparacao
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
BR9102161A (pt) Composicao e processo para revestimento
BR9205493A (pt) Composicao farmaceutica e processo para fabricacao de composicao farmaceutica
BR9205096A (pt) Processo para fabricacao de 2-alcoximetil-acroleina e 3-alcoximetil-quinolina
BR9505571A (pt) Oligômero composto medicamento processo para a produção de um medicamento e uso
BR9200478A (pt) Processo para a preparacao de uma mistura de polimeros e emprego
BR9305707A (pt) Processo para preparaçao de 3-acilestratrienos e acilbenzenos

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal